BetterLife Pharma Inc. (OTCMKTS:BETRF) Sees Significant Increase in Short Interest

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the target of a large increase in short interest in June. As of June 30th, there was short interest totaling 349,174 shares, an increase of 373.4% from the June 15th total of 73,761 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily volume of 570,441 shares, the short-interest ratio is currently 0.6 days.

BetterLife Pharma Price Performance

Shares of BETRF stock traded down $0.00 during mid-day trading on Friday, hitting $0.13. The stock had a trading volume of 24,307 shares, compared to its average volume of 178,438. BetterLife Pharma has a 12-month low of $0.03 and a 12-month high of $0.15. The firm’s 50-day moving average is $0.07 and its two-hundred day moving average is $0.05.

About BetterLife Pharma

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders.